236 related articles for article (PubMed ID: 26630010)
41. Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.
Wiesner T; Lee W; Obenauf AC; Ran L; Murali R; Zhang QF; Wong EW; Hu W; Scott SN; Shah RH; Landa I; Button J; Lailler N; Sboner A; Gao D; Murphy DA; Cao Z; Shukla S; Hollmann TJ; Wang L; Borsu L; Merghoub T; Schwartz GK; Postow MA; Ariyan CE; Fagin JA; Zheng D; Ladanyi M; Busam KJ; Berger MF; Chen Y; Chi P
Nature; 2015 Oct; 526(7573):453-7. PubMed ID: 26444240
[TBL] [Abstract][Full Text] [Related]
42. Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells.
Sattu K; Hochgräfe F; Wu J; Umapathy G; Schönherr C; Ruuth K; Chand D; Witek B; Fuchs J; Li PK; Hugosson F; Daly RJ; Palmer RH; Hallberg B
FEBS J; 2013 Nov; 280(21):5269-82. PubMed ID: 23889739
[TBL] [Abstract][Full Text] [Related]
43. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
[TBL] [Abstract][Full Text] [Related]
44. Novel adaptor protein Shf interacts with ALK receptor and negatively regulates its downstream signals in neuroblastoma.
Takagi D; Tatsumi Y; Yokochi T; Takatori A; Ohira M; Kamijo T; Kondo S; Fujii Y; Nakagawara A
Cancer Sci; 2013 May; 104(5):563-72. PubMed ID: 23360421
[TBL] [Abstract][Full Text] [Related]
45. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.
Bowden ET; Stoica GE; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35862-8. PubMed ID: 12107166
[TBL] [Abstract][Full Text] [Related]
46. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition.
Reiff T; Huber L; Kramer M; Delattre O; Janoueix-Lerosey I; Rohrer H
Development; 2011 Nov; 138(21):4699-708. PubMed ID: 21989914
[TBL] [Abstract][Full Text] [Related]
47. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity.
Bai RY; Dieter P; Peschel C; Morris SW; Duyster J
Mol Cell Biol; 1998 Dec; 18(12):6951-61. PubMed ID: 9819383
[TBL] [Abstract][Full Text] [Related]
48. Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.
Werner MT; Zhao C; Zhang Q; Wasik MA
Blood; 2017 Feb; 129(7):823-831. PubMed ID: 27879258
[TBL] [Abstract][Full Text] [Related]
49. The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase.
Ueno H; Honda H; Nakamoto T; Yamagata T; Sasaki K; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Oncogene; 1997 Jun; 14(25):3067-72. PubMed ID: 9223670
[TBL] [Abstract][Full Text] [Related]
50. Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase.
Bacchiocchi R; Baldanzi G; Carbonari D; Capomagi C; Colombo E; van Blitterswijk WJ; Graziani A; Fazioli F
Blood; 2005 Sep; 106(6):2175-82. PubMed ID: 15928040
[TBL] [Abstract][Full Text] [Related]
51. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells.
Schönherr C; Ruuth K; Kamaraj S; Wang CL; Yang HL; Combaret V; Djos A; Martinsson T; Christensen JG; Palmer RH; Hallberg B
Oncogene; 2012 Dec; 31(50):5193-200. PubMed ID: 22286764
[TBL] [Abstract][Full Text] [Related]
52. CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase with antitumor activity in experimental models of human cancers.
Cheng M; Quail MR; Gingrich DE; Ott GR; Lu L; Wan W; Albom MS; Angeles TS; Aimone LD; Cristofani F; Machiorlatti R; Abele C; Ator MA; Dorsey BD; Inghirami G; Ruggeri BA
Mol Cancer Ther; 2012 Mar; 11(3):670-9. PubMed ID: 22203728
[TBL] [Abstract][Full Text] [Related]
53. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
Ma Z; Cools J; Marynen P; Cui X; Siebert R; Gesk S; Schlegelberger B; Peeters B; De Wolf-Peeters C; Wlodarska I; Morris SW
Blood; 2000 Mar; 95(6):2144-9. PubMed ID: 10706887
[TBL] [Abstract][Full Text] [Related]
54. Identification and characterization of DAlk: a novel Drosophila melanogaster RTK which drives ERK activation in vivo.
Lorén CE; Scully A; Grabbe C; Edeen PT; Thomas J; McKeown M; Hunter T; Palmer RH
Genes Cells; 2001 Jun; 6(6):531-44. PubMed ID: 11442633
[TBL] [Abstract][Full Text] [Related]
55. Expression of a chimeric CSF1R-LTK mediates ligand-dependent neurite outgrowth.
Yamada S; Nomura T; Takano K; Fujita S; Miyake M; Miyake J
Neuroreport; 2008 Nov; 19(17):1733-8. PubMed ID: 18849880
[TBL] [Abstract][Full Text] [Related]
56. Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma.
Chand D; Yamazaki Y; Ruuth K; Schönherr C; Martinsson T; Kogner P; Attiyeh EF; Maris J; Morozova O; Marra MA; Ohira M; Nakagawara A; Sandström PE; Palmer RH; Hallberg B
Dis Model Mech; 2013 Mar; 6(2):373-82. PubMed ID: 23104988
[TBL] [Abstract][Full Text] [Related]
57. Novel TENM3-ALK fusion is an alternate mechanism for ALK activation in neuroblastoma.
Hiwatari M; Seki M; Matsuno R; Yoshida K; Nagasawa T; Sato-Otsubo A; Yamamoto S; Kato M; Watanabe K; Sekiguchi M; Miyano S; Ogawa S; Takita J
Oncogene; 2022 May; 41(20):2789-2797. PubMed ID: 35411036
[TBL] [Abstract][Full Text] [Related]
58. The constitutive activity of the ALK mutated at positions F1174 or R1275 impairs receptor trafficking.
Mazot P; Cazes A; Boutterin MC; Figueiredo A; Raynal V; Combaret V; Hallberg B; Palmer RH; Delattre O; Janoueix-Lerosey I; Vigny M
Oncogene; 2011 Apr; 30(17):2017-25. PubMed ID: 21242967
[TBL] [Abstract][Full Text] [Related]
59. Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase.
Tartari CJ; Gunby RH; Coluccia AM; Sottocornola R; Cimbro B; Scapozza L; Donella-Deana A; Pinna LA; Gambacorti-Passerini C
J Biol Chem; 2008 Feb; 283(7):3743-50. PubMed ID: 18070884
[TBL] [Abstract][Full Text] [Related]
60. HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas.
Bergalet J; Fawal M; Lopez C; Desjobert C; Lamant L; Delsol G; Morello D; Espinos E
Mol Cancer Res; 2011 Apr; 9(4):485-96. PubMed ID: 21343335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
